BioCryst Pharmaceuticals Inc Earnings

The next earnings date for BioCryst Pharmaceuticals Inc is October 29, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of BioCryst Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
10/29/2025	$0.03

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

BioCryst Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/04/2025	---	$0.04	442.86%
05/05/2025	Before Market	$0.00	100.05%
02/24/2025	Before Market	$-0.13	-115.23%
11/04/2024	Before Market	$-0.07	-16.67%
08/05/2024	Before Market	$-0.06	64.71%
05/06/2024	Before Market	$-0.17	19.05%
02/26/2024	Before Market	$-0.28	-16.67%
11/02/2023	Before Market	$-0.19	17.39%
08/03/2023	Before Market	$-0.24	-4.35%
05/03/2023	Before Market	$-0.28	6.67%
02/21/2023	Before Market	$-0.38	-123.53%
11/01/2022	Before Market	$-0.23	20.69%
08/04/2022	Before Market	$-0.32	5.88%
05/05/2022	Before Market	$-0.40	-8.11%
01/10/2022	Before Market	$-0.10	66.67%
11/03/2021	Before Market	$-0.33	-13.79%
08/05/2021	Before Market	$-0.24	0.00%
05/06/2021	Before Market	$-0.36	-33.33%
02/25/2021	Before Market	$-0.34	-36.00%
11/05/2020	Before Market	$-0.26	0.00%
08/06/2020	Before Market	$-0.24	7.69%
05/06/2020	Before Market	$-0.24	0.00%
03/05/2020	Before Market	$-0.02	92.31%
11/06/2019	Before Market	$-0.34	-6.25%
08/06/2019	Before Market	$-0.34	-9.68%
05/08/2019	Before Market	$-0.28	-3.70%
03/04/2019	Before Market	$-0.25	0.00%
11/06/2018	Before Market	$-0.28	-7.69%
08/07/2018	Before Market	$-0.19	20.83%
05/08/2018	Before Market	$-0.26	-36.84%
02/27/2018	Before Market	$-0.20	-33.33%
11/07/2017	Before Market	$-0.18	5.26%
08/07/2017	Before Market	$-0.21	-10.53%
05/04/2017	Before Market	$-0.19	-5.56%
02/27/2017	Before Market	$-0.06	73.91%
11/07/2016	Before Market	$-0.16	33.33%
08/04/2016	Before Market	$-0.22	15.38%
05/05/2016	Before Market	$-0.31	-34.78%
02/23/2016	Before Market	$-0.25	0.00%
11/05/2015	Before Market	$-0.20	0.00%
08/07/2015	Before Market	$0.06	127.27%
05/08/2015	Before Market	$-0.21	16.00%
02/18/2015	Before Market	$-0.16	23.81%
11/06/2014	Before Market	$-0.12	40.00%
08/05/2014	---	$-0.23	-21.05%
05/08/2014	---	$-0.17	0.00%
02/26/2014	---	$-0.09	0.00%
11/05/2013	---	$-0.14	-27.27%
08/08/2013	---	$-0.23	-76.92%
05/07/2013	---	$-0.09	40.00%
02/19/2013	---	$-0.18	-12.50%
11/08/2012	---	$-0.19	24.00%
08/02/2012	---	$-0.25	3.85%
05/07/2012	---	$-0.13	50.00%
02/16/2012	---	$-0.29	-3.57%
11/02/2011	---	$-0.32	-23.08%
08/04/2011	---	$-0.36	-44.00%
05/04/2011	---	$-0.29	-45.00%
02/10/2011	---	$-0.20	4.76%
10/28/2010	---	$-0.24	-41.18%
08/05/2010	---	$-0.23	-4.55%
04/28/2010	---	$-0.06	62.50%
02/04/2010	---	$0.35	288.89%
10/29/2009	---	$-0.28	-27.27%
07/30/2009	---	$-0.23	8.00%
05/08/2009	---	$-0.24	14.29%
02/06/2009	---	$0.26	218.18%
10/31/2008	---	$-0.24	0.00%
08/07/2008	---	$-0.33	-65.00%
05/08/2008	---	$-0.34	-88.89%
03/04/2008	---	$-0.06	84.62%
11/08/2007	---	$-0.32	-14.29%
08/09/2007	---	$-0.24	27.27%
05/09/2007	---	$-0.30	-11.11%
02/07/2007	---	$-0.34	32.00%
11/08/2006	---	$-0.53	-29.27%
08/09/2006	---	$-0.35	-20.69%
04/27/2006	---	$-0.27	-12.50%
02/08/2006	---	$-0.27	6.90%
10/26/2005	---	$-0.29	-20.83%
08/03/2005	---	$-0.22	12.00%
04/21/2005	---	$-0.24	0.00%
02/02/2005	---	$-0.24	7.69%
10/20/2004	---	$-0.24	0.00%
07/21/2004	---	$-0.23	17.86%
04/21/2004	---	$-0.28	-27.27%
02/04/2004	---	$-0.18	10.00%
10/20/2003	---	$-0.19	---
07/30/2003	---	$-0.18	---
03/31/2003	---	$-0.16	---
12/31/2002	---	$-0.16	---
09/30/2002	---	$-0.19	---
06/30/2002	---	$-0.29	---
03/31/2002	---	$-0.32	---
01/30/2002	---	$-0.28	-100.00%
10/24/2001	---	$0.02	115.38%
07/25/2001	---	$-0.08	33.33%
04/25/2001	---	$-0.08	27.27%
02/01/2001	---	$-0.11	8.33%
10/25/2000	---	$-0.09	18.18%
07/26/2000	---	$-0.11	8.33%
04/26/2000	---	$0.10	350.00%
02/02/2000	---	$-0.03	-200.00%
10/21/1999	---	$-0.15	16.67%
07/21/1999	---	$-0.02	75.00%
03/31/1999	---	$-0.16	---
01/27/1999	---	$-0.10	58.33%
10/28/1998	---	$0.19	5.56%
07/22/1998	---	$-0.21	16.00%
03/31/1998	---	$-0.22	---
02/03/1998	---	$-0.21	8.70%
04/28/1997	---	$-0.23	-91.67%
02/10/1997	---	$-0.15	28.57%
10/29/1996	---	$-0.23	17.86%
07/25/1996	---	$-0.11	-320.00%
04/24/1996	---	$-0.20	23.08%
01/29/1996	---	$-0.23	11.54%
10/17/1995	---	$-0.20	13.04%
07/25/1995	Before Market	$-0.18	45.45%
04/28/1995	Before Market	$-0.37	-19.35%
01/31/1995	Before Market	$-0.24	7.69%
10/26/1994	Before Market	$-0.22	29.03%
08/02/1994	Before Market	$-0.25	24.24%

More About BioCryst Pharmaceuticals Inc

Website

https://www.biocryst.com

Country

USA

Full Time Employees

580

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

“BioCryst Pharmaceuticals Inc Earnings” Can Refer to the BioCryst Pharmaceuticals Inc Earnings Date

Some people say “BioCryst Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my BioCryst Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning BioCryst Pharmaceuticals Inc Stock on the Earnings Date

If you own BioCryst Pharmaceuticals Inc stock (BCRX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for BioCryst Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading BioCryst Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More BioCryst Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about BioCryst Pharmaceuticals Inc earnings or anything else related to the stock market.